Transcriptome analyses were performed in the anterior raphe area of mutant mice deficient in the serotonin transporter (5-HTT KO) or overexpressing this protein (5-HTT TG), which exhibit opposite changes in anxiety-related behavior. Among genes with altered expression, the gene encoding the neuropeptide urocortin 1 was down-regulated in 5-HTT KO and up-regulated in 5-HTT TG mice. Expression of the gene encoding cocaine-and-amphetamine-related-peptide, which colocalizes with urocortin 1, was also increased in 5-HTT TG mutants. Real-time RT-PCR confirmed these data and immunoautoradiographic labeling showed that parallel changes in neuropeptide levels were confined to the non-preganglionic Edinger-Westphal nucleus. Thus, 5-HTT expression correlates with that of urocortin 1, suggesting that this peptide can be involved in the behavioral changes observed in 5-HTT mutant mice.
Introduction
Serotonin (5-HT) has been associated with the aetiology of psychiatric disorders including depression and anxiety. Its importance is supported by the efficacy of selective serotonin reuptake inhibitors (SSRIs) to alleviate depression and anxiety-related disorders (Nemeroff and Owens, 2002) , and by the dependence of SSRI therapeutic action on 5-HT synthesis (Delgado et al., 1990) . By taking up 5-HT that has been released in the extracellular space, thereby limiting the interaction of the monoamine with pre-and postsynaptic receptors, the serotonin transporter (5-HTT) is a key protein for serotonergic neurotransmission (Blakely et al., 1991) . In humans, SSRI antidepressants block 5-HTT activity and a decreased density of 5-HTT binding sites has been evidenced in specific brain regions in depressed patients (Arango et al., 2001; Malison et al., 1998; Oquendo et al., 2007) . These data led to thorough investigations aimed at identifying possible variations in the human 5-HTT gene (SLC6A4, for review see Uher and McGuffin, 2008) . A 44-base pair insertion/deletion polymorphism termed 5-HTTLPR in the SLC6A4 promoter region was found to affect SLC6A4 transcription and expression (Lesch et al., 1996) . Specifically, in vitro studies using cultured lymphoblast cell lines or platelets showed that the short allelic variant (s allele) of the 5-HTTLPR polymorphism results in lower 5-HTT expression and 5-HT uptake than the long (l) allele (Greenberg et al., 1999; Lesch et al., 1996) . Association studies subsequently showed that individuals carrying the s allele exhibit increased levels of trait anxiety (Schinka et al., 2004; Sen et al., 2004) , and might have higher risk to develop major depressive disorder upon traumatic life events (Caspi et al., 2003) than individuals having the l allele (see however Risch et al., 2009) . Furthermore, the s allele would also confer a high vulnerability to posttraumatic stress disorder (Lee et al., 2005) . Thus, convergent data strongly support the idea that 5-HTT gene expression is related to the physiopathogenesis of depression and anxiety-related disorders.
Mice with loss or gain of function of the 5-HTT may have some relevance to humans carrying the s or the l allele of the 5-HTTLPR polymorphism, respectively. Knock-out (KO) mice with a targeted disruption of the 5-HTT gene express a functionally inactive 5-HTT (Ravary et al., 2001) as shown by the absence of 5-HTT binding sites and [
3 H]5-HT uptake in these mutants (Bengel et al., 1998) . 5-HT reuptake deficiency in 5-HTT KO mice produces a marked increase in extracellular 5-HT levels (Fabre et al., 2000; Mathews et al., 2004) , that, in turn, triggers adaptive changes in serotonergic neurotransmission (for review see Murphy and Lesch, 2008) . Interestingly, 5-HTT KO mice exhibit an increased anxiety-like behavior (Holmes et al., 2003) and exaggerated neuroendocrine and behavioral responses to stress (Hariri and Holmes, 2006) . In addition, 5-HTT KO mice present an exacerbated depression-like behavior after repeated exposure to forced swim stress suggesting that 5-HTT deficiency negatively influences the capacity to cope with stress (Wellman et al., 2007) . In contrast, in transgenic (TG) mice overexpressing the human 5-HTT and showing a two-to three-fold increase in 5-HTT binding sites, extracellular 5-HT levels in brain areas receiving dense 5-HT innervation such as the hippocampus and the prefrontal cortex are markedly lower than in wild-type (WT) mice (Jennings et al., 2006) . Interestingly, the decreased serotonergic neurotransmission in 5-HTT TG mice was found to correlate with low-anxiety responses in both the elevated plus-maze and hyponeophagia tests (Jennings et al., 2006) . Thus, 5-HTT KO and 5-HTT TG mice provide relevant models to explore further the role of 5-HT in the physiopathology of depression and anxiety-related disorders. In the present study, we analyzed the pattern of gene expression in the anterior raphe area (which contains 5-HT cell bodies of the median and dorsal raphe nuclei) in 5-HTT KO and 5-HTT TG mutants compared to paired WT mice using Illumina MouseRef-8 BeadChips. We then subjected sets of genes differentially expressed in mutants versus WT mice to Ingenuity analysis software. Among the genes affected in mutant mice, ten genes were found to be associated with specific brain-related functions (9 genes for 5-HTT KO mice and 2 genes for 5-HTT TG mice), of which only one, the gene encoding the neuropeptide urocortin 1 (Ucn1), had an altered expression in both 5-HTT KO and 5-HTT TG mutants. We then focused our study on this gene and on the one encoding the neuropeptide cocaine-and-amphetamine-related-transcript (CART) that the Ingenuity analysis showed to be associated, together with Ucn1, with behavioral functions in 5-HTT TG mice. Finally, quantitative real-time RT-PCR and immunoautoradiography investigations were carried out to further characterizing Ucn1 and CART expression in 5-HTT KO and 5-HTT TG mutants versus paired WT mice.
Experimental procedures

Animals
Experiments were performed using homozygous male 5-HTT KO and 5-HTT WT littermates born from heterozygous mutants of C57BL/6J genetic background. Founder 5-HTT KO mice were obtained originally from the colony of K. P. Lesch (Bengel et al., 1998) . 5-HTT TG and paired WT mice (CBA x C57BL/6J mixed background) were obtained from the colony of T. Sharp (Jennings et al., 2006) . Genotyping was performed by PCR as described before (Bengel et al., 1998; Jennings et al., 2006) . Animals were housed in a temperature-controlled room (22 ± 1°C) under 12 h light/dark cycle (lights on at 7:00), with food and water available ad libitum. Animal care and experiments were conducted in accordance with the institutional guidelines that are in compliance with national and international laws and policies (council directive number 19 October 1987, Ministère de l'Agriculture et de la Forêt, Service Vétérinaire de la Santé et de la Protection Animale, permissions #0299 to M.H. and #6269 to L.L.).
Microarray experiments
Microarray experiments were conducted as part as the European Commission Framework 6 integrated Project NEWMOOD and the procedures (selection of the brain region, sample preparation, hybridization, bioinformatics) were agreed upon by the partners of the consortium.
RNA extraction
Male mice (~2 months-old) of each genotype were killed by decapitation between 10:00 and 12:00 A.M., and the brain was removed. The anterior raphe area was dissected (following the procedure of Hamon, 2006) , frozen in liquid nitrogen and stored at − 80°C until use. Total RNA extraction was done using the NucleoSpin RNA II extraction kit (Macherey-Nagel, GmbH & Co. KG, Germany), according to the instructions of the manufacturer, including removal of genomic DNA by DNase treatment. Final eluates were stored at − 80°C until use. RNA integrity was checked by agarose gel electrophoresis, and RNA concentrations were determined using micro-spectrophotometry (NanoDrop Technologies, Houston, TX, USA).
Microarrays
RNA quality control and microarray hybridizations were outsourced to Service XS (Leiden, the Netherlands). RNA integrity of the pooled samples (2 animals per pool) was measured using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). Only pooled samples with a RNA Integrity Number (RIN) above 7.0 were used for microarray experiments. For both groups (5-HTT KO versus paired WT mice and 5-HTT TG versus paired WT mice), four hybridizations were performed (n = 4). Thus, 16 whole-genome expression beadChips (MouseRef-8; Illumina Inc., USA) were used in total.
Microarray data analysis
The raw microarray data was processed using the beadarray (Dunning et al., 2007) preprocessCore (Bolstad et al., 2003) and puma (Rattray et al., 2006 ; PUMA) R package. In the beadarray package, the BackgroundCorrect method used was "minimum", whilst variables for the createbead-summaryData Method were as follows: log = TRUE, n = 10. Data were normalized using the quantile normalization algorithm from the preprocessCore package. Three functions from the puma package were used: pumaComb, pomade and write.reslts, all with default settings.
Biological function analyses
Selected genes were overlaid on the global molecular network developed from information contained in the Ingenuity Pathways Knowledge Base (www.ingenuity.com). This network is composed of 2 million literature-based biological links between genes and bioactive molecules. Sub-networks are built on genes of interest based on their connectivity within this global network taking into account the relative number of network eligible molecules and of molecules analyzed and the total number of molecules in Ingenuity's knowledge base. The top biological functions associated with each network are determined by querying the Ingenuity Pathways Knowledge Base for relationships between the genes in the network and the cellular and organismal functions they impact. The significance of the association between the network and those biological functions is scored using a p-value calculation. Functions having a p-value of less than 0.05 are displayed.
Real-time RT-PCR
To validate the results obtained from microarray analyses, realtime RT-PCR quantifications were performed on the same RNA samples.
2.3.1. cDNA synthesis First-stranded cDNA synthesis (0.5 μg of total RNA per 20 μl reaction) was performed with the SuperScript III Reverse Transcriptase and random primers, as recommended by the manufacturer (Invitrogen, Cergy Pontoise, France).
2.3.2. Semi-quantitative TaqMan real-time RT-PCR PCR amplification in triplicate for each sample was performed (ABI Prism 7300, Applied Biosystems, Courtaboeuf, France) using ABsolute™ QPCR Mixes (ABgene, Courtaboeuf, France) and the Assays-on-Demand Gene Expression probes (Applied Biosystems) for Ucn1 and CART mRNAs and mRNAs from reporter genes encoding glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and hypoxanthine guanine phosphoribosyltransferase (HPRT). The polymerase activation step at 95°C for 15 min was followed by 40 cycles of 15 s at 95°C and 60 s at 60°C. The validity of the results was checked by running appropriate negative controls (substitution of cDNA with water for PCR amplification or omission of reverse transcriptase for the cDNA synthesis step).
Real-time PCR data analysis
The 2 −ΔΔCt method (Schmittgen and Livak, 2008) was used to analyze the relative change in gene expression in mutant versus wild-type mice (RQ Study Software version 1.2; Applied Biosystems). All data [expressed in arbitrary units (A.U.)] were analyzed using both GAPDH and HPRT as references.
2.4. Immunoautoradiography with anti-Ucn1 and anti-CART antibodies 2.4.1. Preparation of brain sections 5-HTT KO, 5-HTT TG and respective paired WT male mice were killed by cervical dislocation, the brain was removed, frozen in isopentane at − 30°C and then stored at − 20°C. Serial coronal sections (20 μm) at the level of the dorsal and median raphe nuclei and surrounding areas were cut at − 20°C according to the stereotaxic atlas of Franklin and Paxinos (2008) , thaw-mounted onto Superfrost Plus® slides and stored at − 80°C until use.
Immunoautoradiolabeling of Ucn1 and CART peptides
Coronal sections (20 μm) were fixed for 5 min at 4°C with 4% paraformaldehyde (Sigma, St. Louis, MO) in phosphate-buffered saline (PBS, pH 7.4; Invitrogen Corporation, Carlsbad, CA), then preincubated for 1 h in PBS supplemented with 3% (w/v) bovine serum albumin and 1% (v/v) donkey serum, and incubated overnight at 4°C with either: 1) the primary rabbit anti-Ucn1 antibody (1:2000 final dilution; Sigma, St. Louis, MO) or 2) the primary rabbit anti-CART antibody (1:10,000 final dilution; Phoenix Pharmaceuticals, Belmont, CA, USA). After extensive washings, sections were incubated for 2 h at room temperature with secondary anti-rabbit [
125 I]-IgG (74-370 kBq/μg, 9 kBq/ml, Perkin Elmer, Courtaboeuf, France), then washed, dried and exposed to βmax film (Amersham) for 4-7 days. Immunoautoradiolabeling of Ucn1 and CART has been done in separate experiments in 5-HTT KO and 5-HTT TG mice.
Autoradiographic quantification
Standard radioactive microscales (GE Healthcare, Orsay, France) were exposed onto each autoradiographic film to ensure that labeling densities were in the linear range. To estimate the intensity of the labeling, optical density on the immunoautoradiograms was measured using a computerized image analysis system SambaTM AUTORADIO (Samba Technologies, Meylan, France) and converted to nCi/g of tissue according to the microscale. In a pilot experiment, non specific labeling was assessed in wild-type mice by omitting the primary antibodies. Non specific labeling was less than 5% of the total signal obtained for both Ucn1 and CART labeling in the npEW nucleus of wild-type mice (data not shown).
Data analyses
For microarray experiments, two filtering criteria were used to define genes that were differentially expressed in 5-HTT KO versus paired WT mice on the one hand and in 5-HTT TG versus paired WT mice on the other hand. First, the expression log 2 -fold change had to be greater than (+ or −) 0.5. Second, the minimum of either the pplr [probability of positive log ratio (MinPprl)] statistic produced by puma had to be less than 0.005.
For real-time RT-PCR and immunoautoradiographic experiments, samples from each genotype were treated in parallel. Statistical analyses were performed using the non-parametric Mann-Whitney test. A difference was considered to reach statistical significance when p-value was ≤0.05.
Results
Whole genome gene expression analysis
To identify genes with clear-cut differences in expression levels in mutants versus WT mice, microarray data were filtered using a fold change criterion, namely a log 2 -fold change cutoff between 0.5 and −0.5 and a statistical value cutoff (MinPplr value b 0.005). Under such conditions, only a few number of transcripts (∼ 0.04% of all genes tested) showed significantly altered expression levels in the anterior raphe area of 5-HTT TG mice compared with paired WT mice ( Table 1 ). As shown in Table 2 , three among these transcripts were upregulated (log 2 -fold change range + 0.66 to + 1.27) and 5 were down-regulated (log 2 -fold change range −0.51 to −0.88). On the other hand, a larger number of genes (∼ 0.31% of all genes tested) appeared to be differentially expressed in the anterior raphe area of 5-HTT KO compared with paired WT mice (Table 1) . Among these genes, 46 were upregulated (log 2 -fold change range + 0.51 to +1.15; Table 3 ) and 31 were down-regulated (log 2 -fold change range −0.52 to −1.49; Table 4) in 5-HTT KO mice versus paired WT mice.
To identify the genes associated with specific brain-and behavioral-related functions, we subjected gene sets listed in Tables 2-4 to Ingenuity functions analysis (Fig. 1) . In case of the 5-HTT TG array data, such analysis allowed identification of the neuropeptides Ucn1 and CART as being significantly associated with nervous system development and behavioral functions. CART was also associated with endocrine system development and functions (Fig. 1A) . On the other hand, 5-HTT KO gene set analysis identified Ucn1 as being associated with behavioral functions. Ucn1, vang-like 2 (Vangl2), the dynein light chain Tctex-type 1 (DYNLT1), neuroplastin (Nptn), formyl peptide receptor 2 (FPR2) and the neurofilament heavy polypeptide (Nefh) appeared to be associated with nervous system development and functions. Interestingly, Nefh, the succinate dehydrogenase subunit D (SdhD), the serpin peptidase inhibitor (Serpina3) and mutL homolog 1 (Mlh1) were found to be associated with neurological diseases (Fig. 1B) .
We then focused our study on the genes identified by Ingeniuty analysis as those playing a role in behavioral functions. In particular, mRNAs encoding the two neuropeptides, Ucn1 (log 2 -fold change: + 1.27; MinPplr b 0.005) and CART (log 2 -fold change: + 0.72; MinPplr b 0.005), were found to be upregulated in 5-HTT TG mice (Table 2 ). In contrast, the gene encoding Ucn1 was down-regulated in the anterior raphe area of 5-HTT KO mice (log 2 -fold change: − 0.56; MinPplr b 0.005, Table 4 ). However, no changes in CART mRNA levels were detected in the latter mutants compared to paired WT mice.
Altogether, these data showed that the expression of a single gene, i.e. the gene encoding Ucn1, was affected in opposite direction in both mouse models.
Real-time RT-PCR validation of differential expression of Ucn1-and CART-encoding genes
To confirm data obtained with microarrays, we measured mRNAs encoding Ucn1 and CART by real-time RT-PCR in the same RNA samples from the anterior raphe area of 5-HTT TG and 5-HTT KO mice compared with their respective WT mice.
After normalization to the reference gene encoding GAPDH, a marked increase (+ 159%; p b 0.001) in Ucn1 mRNA levels was found in the anterior raphe area of 5-HTT TG mice, whereas, in contrast, lower levels of this transcript were measured in 5-HTT KO mice (−55%; p b 0.01) versus respective paired WT mice ( Fig. 2A) . On the other hand, data in Fig. 3A showed that CART mRNA levels were significantly increased in the anterior raphe area of 5-HTT TG mice (+ 72%; p b 0.01), but did not significantly differ in 5-HTT KO mice (p = 0.31) compared to paired WT mice. Parallel experiments using the HPRT encoding gene as the endogenous reference yielded results similar to those found with the GAPDH reference (Figs. 2B and 3B) .
Microarray data concerning Ucn1-and CART-encoding genes were therefore confirmed by real-time RT-PCR in both 5-HTT TG and 5-HTT KO mice.
Quantitative immunoautoradiographic labeling of Ucn1 and CART neuropeptides in anterior raphe area
Immunoautoradiographic experiments using specific anti-Ucn1 antibodies showed that Ucn1 was abundant in a brain area located rostrally to the dorsal raphe nucleus, namely the non- (Figs. 4 and 5) . In contrast, no labeling was detected in the dorsal and median raphe nuclei (data not shown). Similarly, a dense CART immunoautoradiographic labeling was observed in the npEW nucleus (Figs. 4 and 5 ), but this peptide could not be detected in both anterior raphe nuclei (data not shown).
Comparison between mutants and paired WT mice showed lower Ucn1 immunoautoradiographic labeling (−41%) of the npEW nucleus in 5-HTT KO mice (Fig. 4A2 versus 4A1 ). In contrast, CART immunoautoradiographic labeling was similar in 5-HTT KO and paired WT mice (Fig. 4B2 versus 4B1) .
Conversely, 5-HTT TG mice exhibited an increase in Ucn1 (+ 68%) and CART (+ 69%) immunoautoradiographic labeling of the npEW nucleus (Fig. 5A1 versus 5A2 for Ucn1 labeling and Tables 5 and 6 for 5-HTT KO and 5-HTT TG, respectively. We thus observed parallel changes in neuropeptide and mRNA levels suggesting that these changes are directly mediated by transcriptional changes affecting Ucn1 encoding gene in the npEW nucleus of 5-HTT mutant mice.
Discussion
In the present study, we found that expression levels of the gene encoding Ucn1, a neuropeptide belonging to the CRF superfamily, correlated with those of the 5-HTT gene in the anterior raphe area in mice. Thus, 5-HTT TG and 5-HTT KO mice exhibited respectively an increase and a decrease in Ucn1 mRNA levels as evidenced by convergent data from microarray and real-time RT-PCR experiments. In addition to Ucn1 mRNA, CART mRNA was also found to be up-regulated in the same brain region in 5-HTT TG mice, but the latter transcript remained unchanged in 5-HTT KO mice versus WT mice. Interestingly, such changes in gene expression were found to be restricted to a small nucleus in the anterior raphe area: the npEW nucleus. Altogether, our results show that opposite changes in 5-HT reuptake, and therefore of extracellular 5-HT levels in the brain, produce changes in Ucn1-npEW neurons that may in turn mediate the behavioral influences of 5-HT.
Is Ucn1 a biomarker of 5-HT-mediated anxiety trait?
We have explored the hypothesis that molecular changes may underlie 5-HT-mediated behavioral traits in animal models with opposite changes in 5-HTT gene expression and anxiety-related behavior by performing global transcript profiling. The microarray analysis revealed that the gene encoding the neuropeptide Ucn1 exhibited differential expression in the anterior raphe area, which comprises dorsal and median raphe nuclei and surounding areas (see Hamon, 2006) , of 5-HTT TG and 5-HTT KO mice. Thus, and as confirmed by real-time RT-PCR, an almost three-fold increase in Ucn1 gene expression was found in 5-HTT TG mutants, whereas a two-fold decrease was noted in 5-HTT KO mutants versus paired WT mice.
Ucn1 is a 40-amino acid peptide that belongs to the CRF superfamily together with CRF, Ucn2 and Ucn3 neuropeptides (Vaughan et al., 1995) . Ucn1 exhibits a 45% homology with CRF and binds with high affinity to the CRF receptors CRF-R1 and CRF-R2 (Vaughan et al., 1995) . In the mammalian central nervous system, Ucn1 containing cell bodies are especially abundant in a region adjacent to parasympathetic preganglionic cholinergic neurons of the Edinger-Westphal Figure 1 Biological function analysis of genes differentially expressed in the anterior raphe area of 5-HTT TG (A) and 5-HTT KO (B) mutants versus respective paired WT mice. The figure shows the results of analyses using Ingenuity pathway software to determine the biological functions associated with the genes with altered expression levels in mutant mice.
nucleus named the npEW nucleus (Bittencourt et al., 1999; Horn et al., 2008; Kozicz et al., 1998; Weitemier et al., 2005) . In contrast, no immunoreactive perikarya can be detected in the raphe nuclei of the mouse brain (Weitemier et al., 2005) . Such distribution points out that altered Ucn1 gene expression observed here primarily concerned the npEW nucleus. Indeed, quantitative assessment at neuropeptide levels by immunoautoradiography showed lower density of Ucn1 immunolabeling in the npEW nucleus of 5-HTT KO mice compared with wild-type mice. In contrast, 5-HTT TG mice exhibited increased levels of Ucn1 immunolabeling in the npEW nucleus. These results show that regulation of Ucn1 gene expression at the transcriptional level might lead to functional changes in Ucn1 neurotransmission and highlight the potential involvement of the npEW nucleus in associated phenotypical consequences. Changes in 5-HTT gene expression have impact on 5-HT reuptake which, in turn, triggers opposite changes in extracellular 5-HT levels. Thus, 5-HTT KO and 5-HTT TG mice exhibit respectively high and low extracellular 5-HT levels (Fabre et al., 2000; Jennings et al., 2006; Mathews et al., 2004 ) that negatively correlate with Ucn1 gene expression in the npEW nucleus. Together, these findings strongly support the existence of close functional relationships between Ucn1-npEW and 5-HT-raphe neurons, in line with anatomical data showing a dense 5-HT fiber network in the rat npEW nucleus (Clements et al., 1985) .
As mentioned above, 5-HTT KO and 5-HTT TG mice display high-and low-anxiety levels in validated paradigms including the elevated plus-maze (Holmes et al., 2003; Jennings et al., 2006) . Whether 5-HT-mediated behavioral changes may be related to alterations in Ucn1 neurotransmission is a relevant question to be addressed. Interestingly, several studies have implicated Ucn1 neurons in anxiety (for review, see Kozicz, 2007) . In particular, Ucn1 knock-out mice exhibit increased anxiety-like behavior in the elevated plus-maze and the open-field tests (Vetter et al., 2002) . Furthermore, mutant mice lacking the CRF-R2, for which Ucn1 has been proposed to be an endogenous ligand (Vaughan et al., 1995) , also display high anxiety levels (Bale et al., 2000) . The idea that Ucn1 acts as an anxiolytic mediator in rodents is strengthened by findings showing a facilitatory influence of anxiolytics on Ucn1 neurotransmission. Thus, chronic treatment with the benzodiazepine alprazolam increases Ucn1 mRNA expression in the npEW nucleus (Skelton et al., 2000) and administration of the mGlu2/mGlu3 receptor agonist LY354740, which has anxiolytic-like properties, enhances the number of neurons expressing c-Fos in the npEW nucleus in mice (Linden et al., 2004) . Also in humans, Ucn1 expression in the npEW nucleus has been shown to be increased in post mortem brains of male suicide victims with major depression suggesting that Ucn1 neurons in this nucleus might contribute to the pathogenesis of major depression and/or suicidality (Kozicz et al., 2008b) . Here, we found that Ucn1 mRNA levels negatively correlated with anxiety-related behavior in mice. Thus, 5-HTT KO mice exhibited decreased Ucn1 mRNA expression in the npEW nucleus and high anxiety levels (Holmes et al., 2003) and, conversely, 5-HTT TG mice displayed increased Ucn1 mRNA expression in the npEW nucleus and low-anxiety levels (Jennings et al., 2006) . Altogether, our findings and previous data in the literature (see references above) suggest that Ucn1 neurons of the npEW are part of the neuronal circuits underlying the influence of 5-HT on anxiety-related behaviors. However, Ucn2 might also be involved because Corresponding quantitative data are presented in Table 5 . Corresponding quantitative data are presented in Table 6 . Neufeld-Cohen et al. (2009) recently reported that mice lacking both Ucn1 and Ucn2 neuropeptides display a lowanxiety phenotype. The development of lentiviral vectors producing siRNAs to inhibit selectively Ucn1 or Ucn2 expression in both a temporally and spatially restricted manner could be a particularly relevant approach to clarify the respective roles of these neuropetides in anxiety-related behaviors.
A large body of evidence also supports the idea that Ucn1 neurons of the npEW nucleus participate in stress-related responses (for review, see Kozicz, 2007) . Thus, in rodents, acute stressors increase Ucn1 mRNA expression (Okere et al., 2010; Weninger et al., 2000) and activate Ucn1 neurons in this nucleus as reflected by enhanced c-Fos expression (Gaszner et al., 2004; Kozicz, 2003; Weninger et al., 2000) . These changes might play a role in stress adaptation notably because: 1) Ucn1 neurons exhibit a long-lasting activation (for up to 18hours) after an acute stress challenge (Kozicz et al., 2001) , 2) they do not habituate to repeated stress (Korosi et al., 2005 ) and 3) mice lacking Ucn1 display an impaired adaptation to repeated restraint stress (Zalutskaya et al., 2007) . On the other hand, in male tree shrews, chronic psychosocial stress produced a decrease in Ucn1 immunoreactive neurons suggesting that they might be involved in the mechanism enabling the animals to adapt to the stressors (Kozicz et al., 2008a) . Interestingly, 5-HTT KO mice exhibit exaggerated neuroendocrine and behavioral responses to stress (Adamec et al., 2006; Tjurmina et al., 2002) . Indeed, repeated exposure to forced swim stress triggers an exacerbated depression-like behavior in 5-HTT KO mice (Wellman et al., 2007) . It is tempting to speculate that the impaired adaptation to stress in 5-HTT KO mice might be related, at least in part, to altered Ucn1 neurotransmission. Direct investigations of the effects of acute and/or repeated stress on Ucn1 neurotransmission in the npEW nucleus in 5-HTT KO mice would be particularly informative in this regard.
Is there a role for other neuropeptides in the npEW nucleus?
In addition to Ucn1, the npEW nucleus contains numerous neuropeptides including CART (Kozicz et al., 2003) , BDNF (Kozicz et al., 2008b) , neuropeptide W (Kitamura et al., 2006) , nesfastin (Okere et al., 2010) , CCK, and substance P (see Kozicz, 2007) . Interestingly and as observed for Ucn1, increased CART mRNA and protein levels were found in the npEW nucleus in 5-HTT TG mutants compared to paired WT mice. In rodents, CART and Ucn1 are colocalized within the npEW nucleus (Kozicz, 2003) . Such parallel changes in Ucn1 and CART gene expression in the npEW nucleus in 5-HTT TG mice suggest that the increased 5-HT reuptake in these mutants might affect the overall functional activity of neurons in the npEW nucleus. Together with Ucn1, CART very probably contributes to neurobiological mechanisms underlying anxiety because intracerebroventricular administration of CART is known to enhance anxiety-like behavior in rats and mice (for review, see Stanek, 2006) . Furthermore, a decrease in the number of CART immunoreactive neurons in the npEW nucleus has been reported in rats exhibiting a depression-like phenotype evoked by social isolation or olfactory bulbectomy (Dandekar et al., 2009) . Also in humans, a mutation in the gene encoding CART has been associated with early obesity and high scores of anxiety and depression (Miraglia del Giudice et al., 2006) . It is thus attractive to propose that the neuropeptide CART in npEW neurons may participate in the behavioral changes associated with a decreased serotonergic neurotransmission in 5-HTT TG mice (see Jennings et al., 2006) . However, the mechanisms by which CART may modulate anxiety-related behaviors are still unknown. In addition, the fact that CART mRNA levels remained unchanged in 5-HTT KO mice does not support a key role for CART in mediating the influence of 5-HT on anxiety. Interestingly, 5-HTT TG mice are leaner and shorter than paired WT mice despite normal food intake (Pringle et al., 2008) . Given that CART neurons are also involved in feeding behavior and energy expenditure (Rogge et al., 2008) , their involvement in these phenotypical changes should also be explored, notably with regard to CART-5-HT interactions.
Conclusion
An important goal to be reached in the area of mood disorders is the identification of biomarkers that correlate with behavioral traits such as anxiety. Here, our approach indicates that genomic analyses might be suitable for such purposes because we identify a candidate gene, namely the one encoding Ucn1, which expression is altered in mouse models with opposite changes in 5-HTT gene expression and trait anxiety. We notably showed that 5-HT exerts a bidirectional control on Ucn1 gene expression that specifically targets the npEW nucleus. It can therefore be hypothesized that Ucn1-npEW neurons participate in 5-HTmediated anxiety-related behaviors in mice. Although the predictive validity of Ucn1 as a marker of anxiety remains to be assessed in other animal models and in humans, the present findings strongly support the idea that this neuropeptide is critically involved in biological processes underlying psychoaffective disorders.
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